Exciting new ECMO technology awaits compelling scientific evidence for widespread use in adults with respiratory failure.

摘要

MacLaren et al. [1] discuss the exciting potential offered by extracorporeal support, including extracorporeal membrane oxygenation (ECMO). Many uses of ECMO have recently been discussed. These include a technically advanced means of transporting patients with severe respiratory failure [2] and a treatment for acute respiratory distress syndrome (ARDS) following novel H1N1 influenza infection [3]. Extracorporeal support remains an exciting domain of investigation, development and clinical application. Innovations, such as IVOX, abound among developers and practitioners of extracorporeal support [4]. Dr. Bartlett has been a consistent leader and innovator in this field.